vs
Side-by-side financial comparison of BillionToOne, Inc. (BLLN) and STURM RUGER & CO INC (RGR). Click either name above to swap in a different company.
STURM RUGER & CO INC is the larger business by last-quarter revenue ($151.1M vs $83.5M, roughly 1.8× BillionToOne, Inc.). On growth, BillionToOne, Inc. posted the faster year-over-year revenue change (117.4% vs 3.6%). STURM RUGER & CO INC produced more free cash flow last quarter ($12.3M vs $6.5M).
BillionToOne, Inc. is a life sciences and molecular diagnostics firm developing high-precision genetic testing solutions. Its core offerings include non-invasive prenatal tests, oncology diagnostics, and rare disease screening, serving clinical providers and patients mainly in North America.
Sturm, Ruger & Company, Inc., better known by the shortened name Ruger, is an American firearm manufacturing company based in Southport, Connecticut, with production facilities also in Newport, New Hampshire; Mayodan, North Carolina; and Prescott, Arizona. The company was founded in 1949 by Alexander McCormick Sturm and William B. Ruger and has been publicly traded since 1969.
BLLN vs RGR — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $83.5M | $151.1M |
| Net Profit | $5.7M | — |
| Gross Margin | 69.9% | 17.8% |
| Operating Margin | 11.5% | 2.3% |
| Net Margin | 6.8% | — |
| Revenue YoY | 117.4% | 3.6% |
| Net Profit YoY | 138.3% | — |
| EPS (diluted) | $0.10 | $0.22 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $151.1M | ||
| Q3 25 | $83.5M | $126.8M | ||
| Q2 25 | — | $132.5M | ||
| Q1 25 | — | $135.7M | ||
| Q4 24 | — | $145.8M | ||
| Q3 24 | $38.4M | $122.3M | ||
| Q2 24 | — | $130.8M | ||
| Q1 24 | — | $136.8M |
| Q4 25 | — | — | ||
| Q3 25 | $5.7M | $1.6M | ||
| Q2 25 | — | $-17.2M | ||
| Q1 25 | — | $7.8M | ||
| Q4 24 | — | — | ||
| Q3 24 | $-14.9M | $4.7M | ||
| Q2 24 | — | $8.3M | ||
| Q1 24 | — | $7.1M |
| Q4 25 | — | 17.8% | ||
| Q3 25 | 69.9% | 15.1% | ||
| Q2 25 | — | 3.9% | ||
| Q1 25 | — | 22.0% | ||
| Q4 24 | — | 22.8% | ||
| Q3 24 | 52.6% | 18.5% | ||
| Q2 24 | — | 22.3% | ||
| Q1 24 | — | 21.5% |
| Q4 25 | — | 2.3% | ||
| Q3 25 | 11.5% | -2.7% | ||
| Q2 25 | — | -15.6% | ||
| Q1 25 | — | 6.2% | ||
| Q4 24 | — | 7.8% | ||
| Q3 24 | -32.9% | 3.1% | ||
| Q2 24 | — | 6.9% | ||
| Q1 24 | — | 5.5% |
| Q4 25 | — | — | ||
| Q3 25 | 6.8% | 1.2% | ||
| Q2 25 | — | -13.0% | ||
| Q1 25 | — | 5.7% | ||
| Q4 24 | — | — | ||
| Q3 24 | -38.8% | 3.9% | ||
| Q2 24 | — | 6.3% | ||
| Q1 24 | — | 5.2% |
| Q4 25 | — | $0.22 | ||
| Q3 25 | $0.10 | $0.10 | ||
| Q2 25 | — | $-1.05 | ||
| Q1 25 | — | $0.46 | ||
| Q4 24 | — | $0.62 | ||
| Q3 24 | $-1.47 | $0.28 | ||
| Q2 24 | — | $0.47 | ||
| Q1 24 | — | $0.40 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $195.2M | $92.5M |
| Total DebtLower is stronger | $55.0M | — |
| Stockholders' EquityBook value | $-239.5M | $283.8M |
| Total Assets | $327.5M | $342.0M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $92.5M | ||
| Q3 25 | $195.2M | $80.8M | ||
| Q2 25 | — | $101.4M | ||
| Q1 25 | — | $108.3M | ||
| Q4 24 | — | $105.5M | ||
| Q3 24 | — | $96.0M | ||
| Q2 24 | — | $105.6M | ||
| Q1 24 | — | $115.3M |
| Q4 25 | — | — | ||
| Q3 25 | $55.0M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | $283.8M | ||
| Q3 25 | $-239.5M | $279.6M | ||
| Q2 25 | — | $289.3M | ||
| Q1 25 | — | $321.5M | ||
| Q4 24 | — | $319.6M | ||
| Q3 24 | $-242.9M | $314.9M | ||
| Q2 24 | — | $321.5M | ||
| Q1 24 | — | $332.0M |
| Q4 25 | — | $342.0M | ||
| Q3 25 | $327.5M | $342.3M | ||
| Q2 25 | — | $349.5M | ||
| Q1 25 | — | $379.0M | ||
| Q4 24 | — | $384.0M | ||
| Q3 24 | — | $373.5M | ||
| Q2 24 | — | $376.7M | ||
| Q1 24 | — | $385.0M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $13.8M | $15.5M |
| Free Cash FlowOCF − Capex | $6.5M | $12.3M |
| FCF MarginFCF / Revenue | 7.7% | 8.2% |
| Capex IntensityCapex / Revenue | 8.8% | 2.1% |
| Cash ConversionOCF / Net Profit | 2.42× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $38.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $15.5M | ||
| Q3 25 | $13.8M | $12.9M | ||
| Q2 25 | — | $14.7M | ||
| Q1 25 | — | $11.1M | ||
| Q4 24 | — | $20.0M | ||
| Q3 24 | — | $9.4M | ||
| Q2 24 | — | $18.7M | ||
| Q1 24 | — | $7.3M |
| Q4 25 | — | $12.3M | ||
| Q3 25 | $6.5M | $7.0M | ||
| Q2 25 | — | $9.1M | ||
| Q1 25 | — | $10.0M | ||
| Q4 24 | — | $16.4M | ||
| Q3 24 | — | $2.6M | ||
| Q2 24 | — | $10.1M | ||
| Q1 24 | — | $5.6M |
| Q4 25 | — | 8.2% | ||
| Q3 25 | 7.7% | 5.5% | ||
| Q2 25 | — | 6.9% | ||
| Q1 25 | — | 7.4% | ||
| Q4 24 | — | 11.2% | ||
| Q3 24 | — | 2.1% | ||
| Q2 24 | — | 7.7% | ||
| Q1 24 | — | 4.1% |
| Q4 25 | — | 2.1% | ||
| Q3 25 | 8.8% | 4.6% | ||
| Q2 25 | — | 4.2% | ||
| Q1 25 | — | 0.8% | ||
| Q4 24 | — | 2.5% | ||
| Q3 24 | — | 5.5% | ||
| Q2 24 | — | 6.6% | ||
| Q1 24 | — | 1.3% |
| Q4 25 | — | — | ||
| Q3 25 | 2.42× | 8.15× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 1.43× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 1.98× | ||
| Q2 24 | — | 2.27× | ||
| Q1 24 | — | 1.04× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BLLN
| Prenatal | $74.1M | 89% |
| Oncology | $8.7M | 10% |
RGR
| Firearms | $150.6M | 100% |
| Castings | $7.3M | 5% |
